Dutch Electrical Stock News

If you are wondering whether Exor is a bargain hiding in plain sight, you are not alone. This stock has been drawing interest from investors who like to dig beneath the surface of holding companies. Despite a recent 0.9% gain over the last week and a modest 2.0% move over the past month, the share price is still down 18.5% year to date and 17.2% over the last year. This naturally raises the question of whether the market has become too pessimistic. Much of the recent conversation around Exor...

If you are wondering whether ING Groep is still a smart buy after such a huge run up, or if you are late to the party, this breakdown will help you decide whether the current price still makes sense. ING Groep has quietly delivered a 2.2% gain over the last week, 10.6% over the past month, and is up an eye catching 57.7% year to date, with an impressive 73.1% return over the last year and 341.6% over five years. Those moves have come as investors have increasingly rewarded European banks...

Koninklijke BAM Groep nv's ( AMS:BAMNB ) price-to-earnings (or "P/E") ratio of 22.4x might make it look like a sell...

Exor (ENXTAM:EXO) has been drifting after a tough past 3 months, but that pullback is exactly what makes the stock interesting. Let us unpack what the recent slide really signals for long term investors. See our latest analysis for Exor. Zooming out, the share price has slipped to about $72.55 after a weak 90 day share price return, but Exor still shows a positive three year total shareholder return. This suggests long term confidence has not disappeared, just cooled. If Exor has you...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...

Agility Capital Holding Inc. ( AMS:AGIL ) shares have had a really impressive month, gaining 36% after a shaky period...

Wondering if Theon International is still worth a look after its big run, or if the easy money has already been made? This article will walk through what the current share price is really baking in. The stock has been choppy in the short term, down 6.0% over the last week but still up 3.4% over 30 days and 107.6% year to date and 133.2% over the past year. That naturally raises questions about how much upside is left versus the risk of a pullback. Recent headlines have focused on Theon...

When close to half the companies in the Netherlands have price-to-earnings ratios (or "P/E's") below 16x, you may...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Magnum Ice Cream (ENXTAM:MICC) has quietly outpaced the broader market this year, and with earnings growing faster than revenue, investors are starting to ask whether the current share price still reflects fair value. See our latest analysis for Magnum Ice Cream. That modest year to date share price return of 4.78 percent, with the stock now at 13.59 dollars, suggests steady positive momentum is building as investors warm to earnings leverage rather than re rating the story in one big...

If you are wondering whether ASML Holding is still worth buying after its huge run, or if you have missed the boat on this chip equipment giant, you are in the right place to unpack what the current price is really telling us. Despite a recent dip of 2.6% over the last week, ASML is still up 1.7% over the past month, 30.7% year to date, and 32.7% over the last year, which keeps expectations and risk perceptions running high. Those moves are happening against a backdrop of ongoing demand for...

Most readers would already be aware that Aalberts' (AMS:AALB) stock increased significantly by 5.5% over the past...

Heineken Holding (ENXTAM:HEIO) has quietly outperformed the broader European consumer staples space over the past month, and that strength is starting to catch investors attention as they reassess its longer term track record. See our latest analysis for Heineken Holding. Zooming out, Heineken Holding’s roughly 6 percent year to date share price return and double digit 1 year total shareholder return suggest momentum is gradually rebuilding as investors warm to its earnings recovery story. If...

Koninklijke Philips (ENXTAM:PHIA) has been under quiet pressure lately, with the stock slipping over the past month and past 3 months, even as earnings and revenue continue to grow. See our latest analysis for Koninklijke Philips. At around $22.79, the recent 1 month and year to date share price declines suggest momentum has cooled, even though the 3 year total shareholder return near 90% still points to a solid longer term recovery story. If Philips has you thinking about where healthcare...

We think all investors should try to buy and hold high quality multi-year winners. While not every stock performs well...

Key Insights The projected fair value for ArcelorMittal is €35.65 based on 2 Stage Free Cash Flow to Equity...

Theon International (ENXTAM:THEON) has quietly delivered strong gains over the past year, even as recent weeks turned choppy. That mix of momentum and pullback is exactly what makes the stock interesting now. See our latest analysis for Theon International. At a latest share price of $27.45, Theon International has cooled off from its sharp run, with a 7 day share price return of minus 9.11 percent and a 1 year total shareholder return of 131 percent. This still points to strong underlying...

ING Groep recently reported that, as part of its previously announced €1.10 billion share buyback programme, it repurchased 2,017,765 shares between 8 and 12 December 2025, bringing total repurchases to 13,399,920 shares, or about 27.13% of the programme’s maximum value. The buyback, aimed at reducing ING’s share capital, highlights the bank’s ongoing focus on returning excess capital to shareholders alongside its broader digital and sustainable finance initiatives. We’ll now examine how...

With a median price-to-sales (or "P/S") ratio of close to 0.6x in the Commercial Services industry in the Netherlands...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'll want to see a proven...

Some Koninklijke Ahold Delhaize N.V. ( AMS:AD ) shareholders may be a little concerned to see that the President, Frans...

Earlier in December 2025, Galapagos NV reported updated Phase 2 results from its ATALANTA-1 trial of CD19 CAR T-cell therapy GLPG5101 in heavily pretreated mantle cell lymphoma, showing very high response rates, durable outcomes at nine months, and an encouraging safety profile presented at the ASH Annual Meeting. Beyond efficacy, the trial also highlighted the feasibility of decentralized manufacturing, with most patients receiving a fresh GLPG5101 product within seven days of apheresis,...

NN Group N.V.'s ( AMS:NN ) price-to-earnings (or "P/E") ratio of 13.4x might make it look like a buy right now compared...